Location History:
- Lucerne, CH (1999)
- Basel, CH (2002)
Company Filing History:
Years Active: 1999-2002
Title: Brigitte Giesinger: Innovator in Pharmaceutical Chemistry
Introduction
Brigitte Giesinger is a notable inventor based in Basel, Switzerland. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with potential therapeutic applications. With a total of 2 patents to her name, Giesinger's work is recognized for its innovative approach to drug design.
Latest Patents
Giesinger's latest patents include a process for preparing N-(4-hydroxyphenyl)-N′-(4′-aminophenyl)-piperazine and the preparation of aminomethyl-phenylimidazoles. The latter involves the reaction of an ester of a hydroxymethyl-phenylimidazole with an amine, with the acetate ester being particularly preferred. The aminomethyl-phenylimidazoles produced have useful properties as highly selective partial agonists or antagonists at brain dopamine receptor subtypes. One of the preferred compounds prepared is 5-fluoro-2-(4-(2-phenyl-1H-imidazol-5-yl)methyl)-1-piperazinyl)pyrimidine. These esters of hydroxymethyl-phenylimidazoles serve as useful intermediates in pharmaceutical applications.
Career Highlights
Brigitte Giesinger has established herself as a key figure in her field through her innovative research and development efforts. Her work at Schering Corporation has allowed her to explore new avenues in drug formulation and design. Giesinger's contributions have been instrumental in advancing the understanding of selective receptor interactions, which are crucial for developing effective medications.
Collaborations
Giesinger has collaborated with several talented individuals in her field, including Ingrid Mergelsberg and Dinesh Gala. These collaborations have fostered a creative environment that encourages the exchange of ideas and enhances the innovation process.
Conclusion
Brigitte Giesinger's work exemplifies the impact of innovative thinking in pharmaceutical chemistry. Her patents and research contributions continue to influence the development of new therapeutic agents. Giesinger's dedication to her field positions her as a prominent inventor in the industry.